---
category: news
title: "Hepion Pharmaceuticals to Present on CRV431 and AI-POW(TM) at NASH-TAG 2021"
excerpt: "EDISON, NJ / ACCESSWIRE / / Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA) (\"Hepion\"), a clinical stage biopharmaceutical company focused on Artificial Intelligence (\"AI\")-driven therapeutic drug development for the treatment of non-alcoholic steatohepatitis (\"NASH\") and liver disease,"
publishedDateTime: 2021-03-12T02:22:00Z
originalUrl: "https://www.marketwatch.com/press-release/hepion-pharmaceuticals-to-present-on-crv431-and-ai-powtm-at-nash-tag-2021-2021-03-11-142645816"
webUrl: "https://www.marketwatch.com/press-release/hepion-pharmaceuticals-to-present-on-crv431-and-ai-powtm-at-nash-tag-2021-2021-03-11-142645816"
type: article
quality: 67
heat: 77
published: true

provider:
  name: MarketWatch
  domain: marketwatch.com
  images:
    - url: "https://smartableai.github.io/artificial-intelligence/assets/images/organizations/marketwatch.com-50x50.jpg"
      width: 50
      height: 50

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png"
    width: 1200
    height: 630
    isCached: true

related:
  - title: "Hepion Pharmaceuticals to Present on CRV431 and AI-POW(TM) at NASH-TAG 2021"
    excerpt: "EDISON, NJ / ACCESSWIRE / March 11, 2021 / Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA)(“Hepion”), a clinical stage biopharmaceutical company focused on Artificial Intelligence ... challenges in the diagnosis and therapy of NASH and liver fibrosis."
    publishedDateTime: 2021-03-11T12:46:00Z
    webUrl: "https://apnews.com/press-release/accesswire/business-technology-products-and-services-government-regulations-coronavirus-pandemic-90aa446e2c6de7187e150a0f731f45d1"
    type: article
    provider:
      name: Associated Press
      domain: apnews.com
    quality: 37
    images:
      - url: "https://apnews.com/images/PaidContent3.png"
        width: 700
        height: 450
        isCached: true

secured: "NIhr2MMyzJhuQUVFIwnsyqWDscXV8kIblyz3pFo4fRYqasfj1AujBxoYcx+Pg3FTeKWHVOSJm+vRlSO4iAW2YxNHAONGysuZn7cAXk20KbYzafVx03KDQgBzCb8nzqWvzgbDBOj1+1oUPO0MOydBjDfIq3x/IZAdwcm1f6taGm9yQoKSVDHVhZ9h9wnWm6oQ3AwmDZ434tNxF7mMvi+tMJ5TrYzrlVSxeH2oQW8QrtOM+muOEKinSSiDng2yNsUkmipNCf1oQipl9bLYwBdOLzKiZNIpMwuFZFXUaP7ay2RH5J5QvuFF29DoDp10bwOEfmzYU15S8iIvg73D0T8UKJaVC/L0OdKVvCMe4nizgFo=;LKAXh9TNUlLwaNVAE7xrZw=="
---

